Evidence map›Paper›PMID 23059649›Full record

Trial reportJournal of pediatric gastroenterology and nutrition2013

Blood lead concentration is not altered by high-dose vitamin D supplementation in children and young adults with HIV.

Veronique Groleau, Rachel A Herold, Joan I Schall, Julia L Wagner, Kelly A Dougherty, Babette S Zemel, Richard M Rutstein, Virginia A Stallings

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of pediatric gastroenterology and nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01092338 (Safe and Effective Vitamin D Supplementation in HIV), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01092338 phase2completednot on this map

Safe and Effective Vitamin D Supplementation in HIV

TypeinterventionalSponsorChildren's Hospital of PhiladelphiaRan2010 to 2011Enrolled44ConditionsHIV Infections, AIDSArmsCholecalciferol (Vit D3)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Micronutrient supplementation in adults with HIV infection.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Veronique GroleauDivision of Gastroenterology, Hepatology and Nutrition and Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. veronique_g_@hotmail.com
Rachel A Herold
Joan I Schall
Julia L Wagner
Kelly A Dougherty
Babette S Zemel
Richard M Rutstein
Virginia A Stallings
Children's Hospital of Philadelphia · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
Safe and Effective Vitamin D Supplementation in HIVR01AT005531 · NCCIH · CHILDREN'S HOSP OF PHILADELPHIA · PI STALLINGS, VIRGINIA A. · 2009 to 2012
$2.2M
NCCIH NIH HHS R01 AT005531NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1RR024134
6 · The paper itself

Abstract

objectivesOptimal vitamin D status is known to have beneficial health effects and vitamin D supplements are commonly used. It has been suggested that vitamin D supplementation may increase blood lead in children and adults with previous lead exposure. The objective was to determine the safety regarding lead toxicity during 12 weeks of high-dose vitamin D3 supplementation in children and young adults with human immunodeficiency virus (HIV).

methodsSubjects with HIV (8-24 years) were randomized to vitamin D3 supplementation of 4000 or 7000 IU/day and followed at 6 and 12 weeks for changes in serum 25-hydroxy vitamin D (25D) and whole-blood lead concentration. This was a secondary analysis of a larger study of vitamin D3 supplementation in children and adolescents with HIV.

resultsIn 44 subjects (75% African American), the baseline mean ± standard deviation serum 25D was 48.3±18.6 nmol/L. Fifty percent of subjects had baseline serum 25D <50.0 nmol/L. Serum 25D increased significantly with D3 supplementation during the 12 weeks. No subject had a whole-blood lead >5.0 μg/dL at baseline or during subsequent visits. Whole-blood lead and 25D were not correlated at baseline, and were negatively correlated after 12 weeks of supplementation (P=0.014). Whole-blood lead did not differ between those receiving 4000 and 7000 IU of vitamin D3.

conclusionsHigh-dose vitamin D3 supplementation and the concomitant increased serum 25D did not result in increased whole-blood lead concentration in this sample of children and young adults living in a northeastern urban city.

Indexed as

AdolescentAdultCalcifediolChildCholecalciferolDietary SupplementsFemaleHIV InfectionsHumansLeadLead PoisoningLongitudinal StudiesMaleNutritional StatusPhiladelphiaVitamin D DeficiencyCalcifediolCholecalciferolLead

Identifiers

PMID23059649
PMCPMC4132882
OpenAlexW2020692315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.